Breaking News Instant updates and real-time market news.

VRX

Valeant

$18.50

-0.37 (-1.96%)

18:46
02/27/18
02/27
18:46
02/27/18
18:46

Valeant announces licensing agreement with Kaken Pharmaceutical

Valeant announced its subsidiary has entered into an exclusive license agreement with Kaken Pharmaceutical to develop and commercialize products containing a new chemical entity, KP-470, which is an investigational compound for the topical treatment of psoriasis. If approved, KP-470 will represent a novel drug with an alternate mechanism of action in the topical treatment of the disease. Under the terms of the licensing agreement, Kaken has granted to Valeant an exclusive license to develop and commercialize topical products containing KP-470 to treat dermatological and rheumatological disorders and conditions. Valeant will have rights to develop and commercialize products with KP-470 in the United States, Canada, and Western and Eastern Europe. Kaken will receive an upfront cash payment and has the potential to receive certain development-based milestone payments, as well as additional milestone payments based on the achievement of certain annual sales milestones. Additionally, Kaken will receive royalties on Valeant's net sales of the products.

  • 28

    Feb

  • 13

    May

  • 18

    Jun

  • 27

    Aug

VRX Valeant
$18.50

-0.37 (-1.96%)

01/24/18
GSCO
01/24/18
INITIATION
Target $18
GSCO
Sell
Valeant initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Dana Flanders started Valeant Pharmaceuticals with a Sell rating and $18 price target. The company continues to face high leverage, legal risks and competition across key products, Flanders tells investors in a research note. She believes the company's growth rate will be "muted."
01/24/18
01/24/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Valeant (VRX) initiated with a Sell at Goldman Sachs. 2. trivago (TRVG) initiated with a Hold at SunTrust. 3. Holly Energy (HEP) initiated with a Hold at Jefferies. 4. Aramark (ARMK) reinstated with an Outperform at Credit Suisse. 5. The Medicines Co. (MDCO) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/21/18
DBAB
02/21/18
NO CHANGE
Target $20
DBAB
Hold
Deutsche sees rifamycin as possible long-term threat to Valeant
The outlook for Valeant Pharmaceuticals' (VRX) Xifaxan, which represents 13% of the company's revenue, improved last year following safety issues for competitor Viberzi and delays for generic challenger Teva (TEVA), Deutsche Bank analyst Gregg Gilbert tells investors in a research note. More recently, the analyst notes, questions have been raised as to whether Cosmo's rifamycin could pose a threat to Xifaxan, either in the near term from off-label prescribing for irritable bowel syndrome with diarrhea, or longer term if eventually approved for IBS-D. After due diligence, Gilbert believes rifamycin could potentially be a longer-term threat to Xifaxan if it works for IBS-D, but he does not see "material risk" from off-label use in the interim. His model continues to assume mid-single digit Xifaxan sales growth for several years and a generic cliff in 2025. The analyst keeps a Hold rating on Valeant with a $20 price target.
02/26/18
HCWC
02/26/18
NO CHANGE
Target $18
HCWC
Neutral
Valeant price target lowered to $18 from $24 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju lowered his price target for Valeant Pharmaceuticals to $18 after reducing his revenue projections for 2018 ahead of the company's Q4 results. The analyst dropped his 2018 revenue estimate to $8.56B from $9.16B to reflect the impact of divestitures and losses of exclusivity on products losing patent protection or facing further erosion from generic introductions. Selvaraju also sees hurdles to commercial uptake of newly-launched drugs, including new product blocks by reimbursement agencies. He reiterates a Neutral rating on Valeant.

TODAY'S FREE FLY STORIES

LOW

Lowe's

$100.70

-0.69 (-0.68%)

10:05
07/20/18
07/20
10:05
07/20/18
10:05
Options
Lowe's call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:05
07/20/18
07/20
10:05
07/20/18
10:05
General news
Fed's Bullard commented on Trump's policy references: »

Fed's Bullard…

SHOP

Shopify

$173.00

1.32 (0.77%)

, WMT

Walmart

$87.49

-0.24 (-0.27%)

10:03
07/20/18
07/20
10:03
07/20/18
10:03
Periodicals
Walmart acquiring Shopify no longer 'laughable idea,' TechCrunch says 

Reference Link

SHOP

Shopify

$173.00

1.32 (0.77%)

WMT

Walmart

$87.49

-0.24 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

DPLO

Diplomat Pharmacy

$23.05

-1.87 (-7.50%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Diplomat Pharmacy falls -7.4% »

Diplomat Pharmacy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCP

TC PipeLines

$32.55

-2.67 (-7.58%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
TC PipeLines falls -8.3% »

TC PipeLines is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

SKX

Skechers

$24.62

-8.62 (-25.93%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Skechers falls -25.9% »

Skechers is down -25.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBR

Centrais Electricas

$4.57

0.27 (6.28%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Centrais Electricas rises 6.5% »

Centrais Electricas is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBDO

Banco Bradesco

$6.81

(0.00%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Banco Bradesco rises 7.1% »

Banco Bradesco is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOL

Gol Linhas

$7.18

0.61 (9.28%)

10:00
07/20/18
07/20
10:00
07/20/18
10:00
Hot Stocks
Gol Linhas rises 9.3% »

Gol Linhas is up 9.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIT

Wipro

$5.23

0.07 (1.36%)

09:59
07/20/18
07/20
09:59
07/20/18
09:59
Hot Stocks
Breaking Hot Stocks news story on Wipro »

Wipro sees Q2 IT Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

WIT

Wipro

$5.23

0.07 (1.36%)

09:58
07/20/18
07/20
09:58
07/20/18
09:58
Earnings
Wipro reports Q1 EPS 7c, consensus 7c »

Wipro reports Q1 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HON

Honeywell

$151.70

4.13 (2.80%)

09:56
07/20/18
07/20
09:56
07/20/18
09:56
Hot Stocks
Honeywell says proactively managing direct, indirect impacts from tariffs »

Says sales growth was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

MGM

MGM Resorts

$30.64

-0.19 (-0.62%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Hot Stocks
MGM Resorts says 'well-positioned' in Japan »

MGM Resorts International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

BHLB

Berkshire Hills Bancorp

$40.90

-0.05 (-0.12%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Downgrade
Berkshire Hills Bancorp rating change  »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTAS

Cintas

$202.71

8.92 (4.60%)

, STI

SunTrust

$71.16

2.16 (3.13%)

09:55
07/20/18
07/20
09:55
07/20/18
09:55
Options
Early notable gainers among liquid option names on July 20th »

Notable gainers among…

CTAS

Cintas

$202.71

8.92 (4.60%)

STI

SunTrust

$71.16

2.16 (3.13%)

COF

Capital One

$98.50

3.18 (3.34%)

VFC

VF Corp.

$91.37

2.16 (2.42%)

SWK

Stanley Black & Decker

$144.21

4.61 (3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 20

    Jul

CTXS

Citrix

$108.80

-0.86 (-0.78%)

09:54
07/20/18
07/20
09:54
07/20/18
09:54
Downgrade
Citrix rating change  »

Citrix cut to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 08

    Aug

09:45
07/20/18
07/20
09:45
07/20/18
09:45
General news
FX Action: USD-CAD »

FX Action: USD-CAD…

CVLT

Commvault

$69.20

(0.00%)

09:44
07/20/18
07/20
09:44
07/20/18
09:44
Hot Stocks
Commvault appoints two new directors following agreement with Elliott »

Commvault last night…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 08

    Aug

FB

Facebook

$208.08

(0.00%)

, GOOGL

Alphabet Class A

$1,199.26

(0.00%)

09:43
07/20/18
07/20
09:43
07/20/18
09:43
Recommendations
Facebook, Alphabet Class A analyst commentary  »

Facebook expected Q2…

FB

Facebook

$208.08

(0.00%)

GOOGL

Alphabet Class A

$1,199.26

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 25

    Jul

  • 18

    Sep

HON

Honeywell

$147.57

(0.00%)

, SWKS

Skyworks

$102.46

(0.00%)

09:40
07/20/18
07/20
09:40
07/20/18
09:40
Options
Unusually active option classes on open July 20th »

Unusual total active…

HON

Honeywell

$147.57

(0.00%)

SWKS

Skyworks

$102.46

(0.00%)

EWZ

MSCI Brazil Index

$34.46

(0.00%)

GE

General Electric

$13.73

(0.00%)

NUGT

Direxion Gold Miners Bull

$22.20

(0.00%)

JD

JD.com

$36.87

(0.00%)

SLV

iShares Silver Trust

$14.41

(0.00%)

XLI

Industrial Select Sector SPDR

$74.53

(0.00%)

IBM

IBM

$149.25

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 20

    Jul

  • 06

    Aug

  • 14

    Aug

  • 04

    Sep

09:38
07/20/18
07/20
09:38
07/20/18
09:38
General news
Trump trade and rate comments lead to mixed open »

Stock futures fell…

AMZN

Amazon.com

$1,812.85

-29.51 (-1.60%)

09:34
07/20/18
07/20
09:34
07/20/18
09:34
Recommendations
Amazon.com analyst commentary  »

Amazon's AWS to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

SAUC

Diversified Restaurant

$1.22

0.05 (4.27%)

09:33
07/20/18
07/20
09:33
07/20/18
09:33
Syndicate
Diversified Restaurant 6M share Secondary priced at $1.00 »

Dougherty acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLMD

Galmed

$14.99

0.96 (6.84%)

09:31
07/20/18
07/20
09:31
07/20/18
09:31
Initiation
Galmed initiated  »

Galmed initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$521.30

-6.37 (-1.21%)

09:31
07/20/18
07/20
09:31
07/20/18
09:31
Recommendations
Intuitive Surgical analyst commentary  »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 27

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.